Attenzione: i dati modificati non sono ancora stati salvati. Per confermare inserimenti o cancellazioni di voci è necessario confermare con il tasto SALVA/INSERISCI in fondo alla pagina
IRIS
Background: Human immunodeficiency virus (HIV) remains a public health priority in Latin America. While the burden of HIV is historically concentrated in urban areas and high-risk groups, subnational estimates that cover multiple countries and years are missing. This paucity is partially due to incomplete vital registration (VR) systems and statistical challenges related to estimating mortality rates in areas with low numbers of HIV deaths. In this analysis, we address this gap and provide novel estimates of the HIV mortality rate and the number of HIV deaths by age group, sex, and municipality in Brazil, Colombia, Costa Rica, Ecuador, Guatemala, and Mexico. Methods: We performed an ecological study using VR data ranging from 2000 to 2017, dependent on individual country data availability. We modeled HIV mortality using a Bayesian spatially explicit mixed-effects regression model that incorporates prior information on VR completeness. We calibrated our results to the Global Burden of Disease Study 2017. Results: All countries displayed over a 40-fold difference in HIV mortality between municipalities with the highest and lowest age-standardized HIV mortality rate in the last year of study for men, and over a 20-fold difference for women. Despite decreases in national HIV mortality in all countries—apart from Ecuador—across the period of study, we found broad variation in relative changes in HIV mortality at the municipality level and increasing relative inequality over time in all countries. In all six countries included in this analysis, 50% or more HIV deaths were concentrated in fewer than 10% of municipalities in the latest year of study. In addition, national age patterns reflected shifts in mortality to older age groups—the median age group among decedents ranged from 30 to 45 years of age at the municipality level in Brazil, Colombia, and Mexico in 2017. Conclusions: Our subnational estimates of HIV mortality revealed significant spatial variation and diverging local trends in HIV mortality over time and by age. This analysis provides a framework for incorporating data and uncertainty from incomplete VR systems and can help guide more geographically precise public health intervention to support HIV-related care and reduce HIV-related deaths.
Mapping subnational HIV mortality in six Latin American countries with incomplete vital registration systems
Cork M. A.;Henry N. J.;Watson S.;Croneberger A. J.;Baumann M.;Letourneau I. D.;Yang M.;Serfes A. L.;Abbas J.;Abbasi N.;Abbastabar H.;Abreu L. G.;Abu-Gharbieh E.;Achappa B.;Adabi M.;Adal T. G.;Adegbosin A. E.;Adekanmbi V.;Adetokunboh O. O.;Agudelo-Botero M.;Ahinkorah B. O.;Ahmadi K.;Ahmed M. B.;Alhassan R. K.;Alipour V.;Almasi-Hashiani A.;Alvis-Guzman N.;Ancuceanu R.;Andrei T.;Anvari D.;Aqeel M.;Arabloo J.;Aremu O.;Asaad M.;Atnafu D. D.;Atreya A.;Quintanilla B. P. A.;Azari S.;B D. B.;Baig A. A.;Banach M.;Bante S. A.;Barboza M. A.;Basu S.;Bedi N.;Ramirez D. F. B.;Bensenor I. M.;Beyene F. -H. Y.;Bezabih Y. M.;Bhagavathula A. S.;Bhardwaj N.;Bhardwaj P.;Bhattacharyya K.;Bhutta Z. A.;Bijani A.;Birlik S. M.;Bitew Z. W.;Bohlouli S.;Boloor A.;Brunoni A. R.;Butt Z. A.;Cardenas R.;Carvalho F.;Castaldelli-Maia J. M.;Casta-neda-orjuela C. A.;Charan J.;Chatterjee S.;Chattu V. K.;Chattu S. K.;Chowdhury M. A. K.;Christopher D. J.;Chu D. -T.;Cook A. J.;Cormier N. M.;Dahlawi S. M. A.;Daoud F.;Davila-Cervantes C. A.;Weaver N. D.;De la Hoz F. P.;Demeke F. M.;Denova-Gutierrez E.;Deribe K.;Deuba K.;Dharmaratne S. D.;Dhungana G. P.;Diaz D.;Djalalinia S.;Duraes A. R.;Eagan A. W.;Earl L.;Effiong A.;Zaki M. E. S.;Tantawi M. E.;Elayedath R.;El-Jaafary S. I.;Faraon E. J. A.;Faro A.;Fattahi N.;Fauk N. K.;Fernandes E.;Filip I.;Fischer F.;Foigt N. A.;Foroutan M.;Fukumoto T.;Gad M. M.;Gebremariam T. B. B.;Gebremed-Hin K. B.;Gebremeskel G. G.;Gesesew H. A.;Ghadiri K.;Ghashghaee A.;Gilani S. A.;Golechha M.;Gori U.;Goulart A. C.;Goulart B. N. G.;Gugnani H. C.;Guimaraes M. D. C.;Guimaraes R. A.;Guo Y. -I.;Gupta R.;Haeuser E.;Haider M. R.;Haile T. G.;Haj-Mirzaian A.;Haj-Mirzaian A.;Hanif A.;Hargono A.;Hariyani N.;Hassanipour S.;Hassankhani H.;Hayat K.;Herteliu C.;Ho H. C.;Holla R.;Hosseinzadeh M.;Househ M.;Hwang B. -F.;Ibeneme C. U.;Ibitoye S. E.;Ile-Sanmi O. S.;Ilic M. D.;Ilic I. M.;Iqbal U.;Jahagir-Dar D.;Jain V.;Jakovljevic M.;Jha R. P.;Johnson K. B.;Joseph N.;Joukar F.;Kalankesh L. R.;Kalhor R. -L.;Kanchan T.;Matin B. K.;Karch A.;Karimi S. E.;Kassahun G.;Kayode G. A.;Karyani A. K.;Keramati M.;Khalid N.;Khan E. A.;Khan G.;Khan M. N. N.;Khatab K.;Kianipour N.;Kim Y. J.;Kisa S.;Kisa A.;Kosen S.;Laxminarayana S. L. K.;Koyanagi A.;Krishan K.;Defo B. K.;Kuchenbecker R. S.;Kulkarni V.;Kumar N.;Kumar M.;Kurmi O. P.;Kusuma D.;Vecchia C. L.;Lal D. K.;Landires I.;Lasrado S.;Lee P. H.;Legrand K. E.;Li B.;Li S.;Liu X.;Amin Hawraz;Machado D. B.;Madi D.;Magis-Rodriguez C.;Malta D. C.;Mansournia M. A.;Manzar M. D.;Arnedo C. A. M.;Martins-Melo F. R.;Masoumi S. Z.;Mayala B. K.;Medina-Solis C. E.;Memish Z. A.;Mendoza W.;Menezes R. G.;Mestrovic T.;Mirica A.;Moazen B.;Mohammad Y.;Mezerji N. M. G.;Mohammadian-Hafshejani A.;Mohammadpourhodki R.;Mohammed S.;Mokdad A. H.;Moni M. A.;Moradi M.;Moradi Y.;Moradzadeh R.;Moraga P.;Khaneghah A. M. -S.;Mustafa G.;Mwanri L.;Nagaraja R.;Nagarajan A. J.;Naim-Zada M. D.;Nascimento B. R.;Naveed D. M.;Nayak V. C.;Nazari J.;Negash H.;Negoi I.;Nepal S.;Nguefack-Tsague G.;Nguyen C. T.;Nguyen H. L. T.;Nikbakhsh R.;Noubiap J. J.;Nunez-Samudio V.;Oancea B.;Ogbo F. A.;Olagunju A. T.;Otstav-Nov N.;A M. P.;Padubidri J. R.;Pandi-Perumal S. R.;Pardo-Montano A. M.;Patel U. K.;Pawar S.;Peprah E. K.;Pereira A.;Perkins S.;Pescarini J. M.;Pokhrel K. N.;Postma M. J.;Pot-Too F. H.;Prada S. I.;Preotescu L.;Pribadi D. R. A.;Radfar A.;Rahim F.;Rahman M. H. U.;Rahmani A. M.;Ramezanzadeh K.;Rana J.;Ranabhat C. L.;Rao S. J.;Rathi P.;Rawaf S.;Rawaf D. L.;Rawassizadeh R.;Renjith V.;Rezaei N.;Rezapour A.;Ribeiro A. I.;Roever L.;Rubagotti E.;Rumisha S. F.;Rwegerera G. M.;Sagar R.;Sajadi S. M.;Salem M. R.;Samy A. M.;Sarmiento-Suarez R.;Sathian B.;Schaeffer L. E.;Schneider I. J. C.;Seidu A. -A.;Sha F.;Shaikh M. A.;Sharafi K. -M.;Sheikh A.;Shibuya K.;Shin J. I.;Silva D. A. S.;Singh J. A.;Skryabin V. Y.;Skryabina A. A.;Sligar A.;Soheili A.;Steuben K. M.;Sufiyan M. B.;Tadesse E. G.;Tesema A. K. T.;Tesfay F. H.;Thapar R.;Thompson R. L.;Tovani-Palone M. R.;Tran B. X.;Tsegaye G. W.;Umeokonkwo C. D.;Unnikrish-Nan B.;Vasseghian Y.;Violante F. S.;Vo B.;Vu G. T.;Waheed Y.;Wang Y. -P.;Wang Y.;Ward P.;Welay F. T.;Westerman R.;Wickramasinghe N. D.;Yaya S.;Yip P.;Yonemoto N.;Yu C.;Yuce D.;Yusefzadeh H.;Zamanian M.;Zastroz-Hin M. S.;Zhang Z. -J.;Zhang Y.;Ziapour A.;Hay S. I.;Dwyer-Lindgren L.
2021-01-01
Abstract
Background: Human immunodeficiency virus (HIV) remains a public health priority in Latin America. While the burden of HIV is historically concentrated in urban areas and high-risk groups, subnational estimates that cover multiple countries and years are missing. This paucity is partially due to incomplete vital registration (VR) systems and statistical challenges related to estimating mortality rates in areas with low numbers of HIV deaths. In this analysis, we address this gap and provide novel estimates of the HIV mortality rate and the number of HIV deaths by age group, sex, and municipality in Brazil, Colombia, Costa Rica, Ecuador, Guatemala, and Mexico. Methods: We performed an ecological study using VR data ranging from 2000 to 2017, dependent on individual country data availability. We modeled HIV mortality using a Bayesian spatially explicit mixed-effects regression model that incorporates prior information on VR completeness. We calibrated our results to the Global Burden of Disease Study 2017. Results: All countries displayed over a 40-fold difference in HIV mortality between municipalities with the highest and lowest age-standardized HIV mortality rate in the last year of study for men, and over a 20-fold difference for women. Despite decreases in national HIV mortality in all countries—apart from Ecuador—across the period of study, we found broad variation in relative changes in HIV mortality at the municipality level and increasing relative inequality over time in all countries. In all six countries included in this analysis, 50% or more HIV deaths were concentrated in fewer than 10% of municipalities in the latest year of study. In addition, national age patterns reflected shifts in mortality to older age groups—the median age group among decedents ranged from 30 to 45 years of age at the municipality level in Brazil, Colombia, and Mexico in 2017. Conclusions: Our subnational estimates of HIV mortality revealed significant spatial variation and diverging local trends in HIV mortality over time and by age. This analysis provides a framework for incorporating data and uncertainty from incomplete VR systems and can help guide more geographically precise public health intervention to support HIV-related care and reduce HIV-related deaths.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1536024
Citazioni
ND
92
90
social impact
Conferma cancellazione
Sei sicuro che questo prodotto debba essere cancellato?
simulazione ASN
Il report seguente simula gli indicatori relativi alla propria produzione scientifica in relazione alle soglie ASN 2023-2025 del proprio SC/SSD. Si ricorda che il superamento dei valori soglia (almeno 2 su 3) è requisito necessario ma non sufficiente al conseguimento dell'abilitazione. La simulazione si basa sui dati IRIS e sugli indicatori bibliometrici alla data indicata e non tiene conto di eventuali periodi di congedo obbligatorio, che in sede di domanda ASN danno diritto a incrementi percentuali dei valori. La simulazione può differire dall'esito di un’eventuale domanda ASN sia per errori di catalogazione e/o dati mancanti in IRIS, sia per la variabilità dei dati bibliometrici nel tempo. Si consideri che Anvur calcola i valori degli indicatori all'ultima data utile per la presentazione delle domande.
La presente simulazione è stata realizzata sulla base delle specifiche raccolte sul tavolo ER del Focus Group IRIS coordinato dall’Università di Modena e Reggio Emilia e delle regole riportate nel DM 589/2018 e allegata Tabella A. Cineca, l’Università di Modena e Reggio Emilia e il Focus Group IRIS non si assumono alcuna responsabilità in merito all’uso che il diretto interessato o terzi faranno della simulazione. Si specifica inoltre che la simulazione contiene calcoli effettuati con dati e algoritmi di pubblico dominio e deve quindi essere considerata come un mero ausilio al calcolo svolgibile manualmente o con strumenti equivalenti.